MBX Biosciences CEO Makes Bold $16 Share Purchase Amid Market Volatility—Is Insider Confidence a Signal for Upside?
CEO Kent’s $16 share buy at MBX Biosciences shows strong conviction amid 52‑week swings, signaling potential upside for cautious investors.
3 minutes to read

